1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Artal Group S.A. Buys Moderna Inc, NVIDIA Corp, Acceleron Pharma Inc, Sells Clementia Pharmaceuticals Inc, AnaptysBio Inc, bluebird bio Inc

Luxembourg, N4, based Investment company Artal Group S.A. buys Moderna Inc, NVIDIA Corp, Acceleron Pharma Inc, Epizyme Inc, Blueprint Medicines Corp, Ascendis Pharma A/S, Mirati Therapeutics Inc, InflaRx NV, WAVE Life Sciences, The Medicines Co, Dicerna Pharmaceuticals Inc, Huazhu Group, Solid Biosciences Inc, Apellis Pharmaceuticals Inc, Intercept Pharmaceuticals Inc, Sage Therapeutics Inc, Alder BioPharmaceuticals Inc, Tricida Inc, Selecta Biosciences Inc, TG Therapeutics Inc, Precision BioSciences Inc, Replimune Group Inc, Aravive Inc, Merus NV, AC Immune SA, CytomX Therapeutics Inc, sells Clementia Pharmaceuticals Inc, AnaptysBio Inc, bluebird bio Inc, argenx SE, FibroGen Inc, Audentes Therapeutics Inc, Madrigal Pharmaceuticals Inc, Homology Medicines Inc, Momenta Pharmaceuticals Inc, Marinus Pharmaceuticals Inc, Chimerix Inc, Y-mAbs Therapeutics Inc during the 3-months ended 2019Q1, according to the most recent filings of the investment company, Artal Group S.A.. As of 2019Q1, Artal Group S.A. owns 96 stocks with a total value of $2.4 billion. These are the details of the buys and sells.

For the details of Artal Group S.A.'s stock buys and sells, go to https://www.gurufocus.com/guru/artal+group+s.a./current-portfolio/portfolio

These are the top 5 holdings of Artal Group S.A.
  1. Lexicon Pharmaceuticals Inc (LXRX) - 60,240,864 shares, 14.18% of the total portfolio.
  2. Weight Watchers International Inc (WW) - 14,818,300 shares, 12.64% of the total portfolio.
  3. Moderna Inc (MRNA) - 5,006,298 shares, 4.31% of the total portfolio. New Position
  4. BeiGene Ltd (BGNE) - 600,000 shares, 3.35% of the total portfolio.
  5. Acceleron Pharma Inc (XLRN) - 1,650,000 shares, 3.25% of the total portfolio. Shares added by 57.14%
New Purchase: Moderna Inc (MRNA)

Artal Group S.A. initiated holding in Moderna Inc. The purchase prices were between $14.45 and $23.7, with an estimated average price of $18.52. The stock is now traded at around $23.05. The impact to a portfolio due to this purchase was 4.31%. The holding were 5,006,298 shares as of .

New Purchase: NVIDIA Corp (NVDA)

Artal Group S.A. initiated holding in NVIDIA Corp. The purchase prices were between $127.99 and $183.94, with an estimated average price of $154.95. The stock is now traded at around $169.91. The impact to a portfolio due to this purchase was 3.19%. The holding were 420,000 shares as of .

New Purchase: Epizyme Inc (EPZM)

Artal Group S.A. initiated holding in Epizyme Inc. The purchase prices were between $5.98 and $13.98, with an estimated average price of $11.1. The stock is now traded at around $11.97. The impact to a portfolio due to this purchase was 0.92%. The holding were 1,750,000 shares as of .

New Purchase: Ascendis Pharma A/S (ASND)

Artal Group S.A. initiated holding in Ascendis Pharma A/S. The purchase prices were between $62.15 and $129.99, with an estimated average price of $86.75. The stock is now traded at around $122.34. The impact to a portfolio due to this purchase was 0.62%. The holding were 125,000 shares as of .

New Purchase: Mirati Therapeutics Inc (MRTX)

Artal Group S.A. initiated holding in Mirati Therapeutics Inc. The purchase prices were between $42.42 and $78.95, with an estimated average price of $67.65. The stock is now traded at around $67.42. The impact to a portfolio due to this purchase was 0.54%. The holding were 175,000 shares as of .

New Purchase: WAVE Life Sciences Ltd (WVE)

Artal Group S.A. initiated holding in WAVE Life Sciences Ltd. The purchase prices were between $32.69 and $47.91, with an estimated average price of $40.58. The stock is now traded at around $27.22. The impact to a portfolio due to this purchase was 0.41%. The holding were 250,000 shares as of .

Added: Acceleron Pharma Inc (XLRN)

Artal Group S.A. added to a holding in Acceleron Pharma Inc by 57.14%. The purchase prices were between $39.06 and $48.05, with an estimated average price of $43.83. The stock is now traded at around $41.19. The impact to a portfolio due to this purchase was 1.18%. The holding were 1,650,000 shares as of .

Added: Blueprint Medicines Corp (BPMC)

Artal Group S.A. added to a holding in Blueprint Medicines Corp by 41.67%. The purchase prices were between $48.7 and $86.6, with an estimated average price of $73.56. The stock is now traded at around $82.35. The impact to a portfolio due to this purchase was 0.85%. The holding were 850,000 shares as of .

Added: InflaRx NV (IFRX)

Artal Group S.A. added to a holding in InflaRx NV by 65.00%. The purchase prices were between $31.16 and $48.62, with an estimated average price of $37.15. The stock is now traded at around $43.09. The impact to a portfolio due to this purchase was 0.52%. The holding were 825,000 shares as of .

Added: The Medicines Co (MDCO)

Artal Group S.A. added to a holding in The Medicines Co by 75.00%. The purchase prices were between $17.86 and $28.02, with an estimated average price of $23.46. The stock is now traded at around $32.11. The impact to a portfolio due to this purchase was 0.36%. The holding were 700,000 shares as of .

Added: Dicerna Pharmaceuticals Inc (DRNA)

Artal Group S.A. added to a holding in Dicerna Pharmaceuticals Inc by 86.53%. The purchase prices were between $9.74 and $14.65, with an estimated average price of $11.47. The stock is now traded at around $11.06. The impact to a portfolio due to this purchase was 0.28%. The holding were 979,275 shares as of .

Added: Solid Biosciences Inc (SLDB)

Artal Group S.A. added to a holding in Solid Biosciences Inc by 140.00%. The purchase prices were between $7.19 and $32.37, with an estimated average price of $16.87. The stock is now traded at around $9.76. The impact to a portfolio due to this purchase was 0.27%. The holding were 1,200,000 shares as of .

Sold Out: Clementia Pharmaceuticals Inc (CMTA)

Artal Group S.A. sold out a holding in Clementia Pharmaceuticals Inc. The sale prices were between $11.64 and $26.17, with an estimated average price of $18.43.

Sold Out: AnaptysBio Inc (ANAB)

Artal Group S.A. sold out a holding in AnaptysBio Inc. The sale prices were between $61.38 and $75.39, with an estimated average price of $69.01.

Sold Out: Homology Medicines Inc (FIXX)

Artal Group S.A. sold out a holding in Homology Medicines Inc. The sale prices were between $19.76 and $29.57, with an estimated average price of $24.76.

Sold Out: Momenta Pharmaceuticals Inc (MNTA)

Artal Group S.A. sold out a holding in Momenta Pharmaceuticals Inc. The sale prices were between $10.47 and $15.1, with an estimated average price of $12.75.

Sold Out: Marinus Pharmaceuticals Inc (MRNS)

Artal Group S.A. sold out a holding in Marinus Pharmaceuticals Inc. The sale prices were between $2.87 and $4.28, with an estimated average price of $3.59.

Sold Out: Y-mAbs Therapeutics Inc (YMAB)

Artal Group S.A. sold out a holding in Y-mAbs Therapeutics Inc. The sale prices were between $18.21 and $26.21, with an estimated average price of $21.95.



Here is the complete portfolio of Artal Group S.A.. Also check out:

1. Artal Group S.A.'s Undervalued Stocks
2. Artal Group S.A.'s Top Growth Companies, and
3. Artal Group S.A.'s High Yield stocks
4. Stocks that Artal Group S.A. keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)